儿童家庭机械通气24年国际演变:有创与无创比较综述
该综述检索2000至2023年Medline/PubMed上儿童家庭机械通气(HMV)的调查文献,分析32项国际报告共8815例儿童。结果显示神经肌肉疾病占37%为最大群体,无创通气(NIV)使用比例显著高于有创通气(IMV)(72% vs 28%),且近年NIV应用增多,但IMV在低龄儿童中仍常见。
要点
- 神经肌肉疾病是儿童HMV最主要病因(37%),其次为心肺疾病(16%)和中枢神经系统疾病(16%)。
- NIV使用显著多于IMV(6362例 vs 2453例,72% vs 28%),但IMV起始年龄更小(3.3±3.3岁 vs 8.2±4.4岁)。
- IMV患儿接受日间额外HMV的比例更高(69% vs 10%),近年NIV使用呈增长趋势。
核心结论
- 神经肌肉疾病是儿童HMV最大群体,NIV近年更受青睐,但IMV在低龄儿童中仍普遍。
研究设计与样本
- 检索Medline/PubMed上2000至2023年儿童HMV调查文献,分析32项国际报告共8815例儿童(59%男孩)。
主要发现
- 神经肌肉疾病占37%,心肺疾病占16%,中枢神经系统疾病占16%,上气道疾病占13%,其他占10%,中枢性低通气占4%,胸廓疾病占3%,遗传/先天性疾病占1%。
- HMV起始平均年龄6.7±3.7岁(范围0.5-14.7),年龄分布呈双峰(约1-2岁和14-15岁)。
- NIV使用例数显著多于IMV(6362 vs 2453,p=0.03),比例72% vs 28%(p=0.048)。
- IMV起始平均年龄3.3±3.3岁,NIV为8.2±4.4岁(p<0.01);IMV患儿接受日间额外HMV比例更高(69% vs 10%,p<0.001)。
- 近两年(2020-2023)NIV使用增加,遗传/先天性疾病、中枢神经系统疾病和其他疾病组需HMV患者增多;儿童HMV估计患病率为7.4/100 000儿童。
临床怎么用
- 临床选择儿童HMV模式时应考虑疾病类型和年龄,神经肌肉疾病患儿可优先评估NIV,低龄儿童需关注IMV可能性。
局限性
- 基于已发表调查文献,可能存在发表偏倚和地区差异,各国NIV经验不同影响模式选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Home mechanical ventilation (HMV) is the treatment for chronic hypercapnic alveolar hypoventilation. The proportion and evolution of paediatric invasive (IMV) and non-invasive (NIV) HMV across the world is unknown, as well as the disorders and age of children using HMV. METHODS: Search of Medline/PubMed for publications of paediatric surveys on HMV from 2000 to 2023. RESULTS: Data from 32 international reports, representing 8815 children (59% boys) using HMV, were analysed. A substantial number of children had neuromuscular disorders (NMD; 37%), followed by cardiorespiratory (Cardio-Resp; 16%), central nervous system (CNS; 16%), upper airway (UA; 13%), other disorders (Others; 10%), central hypoventilation (4%), thoracic (3%) and genetic/congenital disorders (Gen/Cong; 1%). Mean age±SD (range) at HMV initiation was 6.7±3.7 (0.5-14.7) years. Age distribution was bimodal, with two peaks around 1-2 and 14-15 years. The number and proportion of children using NIV was significantly greater than that of children using IMV (n=6362 vs 2453, p=0.03; 72% vs 28%, p=0.048), with wide variations among countries, studies and disorders. NIV was used preferentially in the preponderance of children affected by UA, Gen/Cong, Thoracic, NMD and Cardio-Resp disorders. Children with NMD still receiving primary invasive HMV were mainly type I spinal muscular atrophy (SMA). Mean age±SD at initiation of IMV and NIV was 3.3±3.3 and 8.2±4.4 years (p<0.01), respectively. The rate of children receiving additional daytime HMV was higher with IMV as compared with NIV (69% vs 10%, p<0.001). The evolution of paediatric HMV over the last two decades consists of a growing number of children using HMV, in parallel to an increasing use of NIV in recent years (2020-2023). There is no clear trend in the profile of children over time (age at HMV). However, an increasing number of patients requiring HMV were observed in the Gen/Cong, CNS and Others groups. Finally, the estimated prevalence of paediatric HMV was calculated at 7.4/100 000 children. CONCLUSIONS: Patients with NMD represent the largest group of children using HMV. NIV is increasingly favoured in recent years, but IMV is still a prevalent intervention in young children, particularly in countries indicating less experience with NIV.
引用
- Toussaint M, van Hove O, Leduc D, et al. Invasive versus non-invasive paediatric home mechanical ventilation: review of the international evolution over the past 24 years. Thorax. 2024. PMID: 38365452. doi:10.1136/thorax-2023-220888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。